We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+12.72%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$31.4B
AUM Growth
+$2.72B
Cap. Flow
+$31.8M
Cap. Flow %
0.1%
Top 10 Hldgs %
39.84%
Holding
1,057
New
52
Increased
555
Reduced
391
Closed
42

Top Buys

Rank Stock Value
1
SSRM icon
SSR Mining
SSRM
+$217M
2
KGC icon
Kinross Gold
KGC
+$120M
3
BTG icon
B2Gold
BTG
+$94.6M
4
GFI icon
Gold Fields
GFI
+$80.9M
5
AMAT icon
Applied Materials
AMAT
+$76.4M

Sector Composition

Rank Sector Weight
1 Materials 59.5%
2 Technology 13.57%
3 Healthcare 5.48%
4 Financials 3.32%
5 Consumer Discretionary 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
201
Nike
NKE
$61.9B
$16.8M 0.05%
133,585
-518,761
-80% -$55.7M
EQNR icon
202
Equinor
EQNR
$97.7B
$16.7M 0.05%
+1,185,200
New +$18.3M
ABBV icon
203
AbbVie
ABBV
$443B
$16.6M 0.05%
189,657
-5,900
-3% -$555K
XEC
204
DELISTED
CIMAREX ENERGY CO
XEC
$16.6M 0.05%
682,588
+454,253
+199% +$12M
ELAN icon
205
Elanco Animal Health
ELAN
$13.2B
$16.2M 0.05%
580,800
-232,914
-29% -$5.9M
SRE.PRA
206
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
$16M 0.05%
162,919
-3,479
-2% -$355K
NOV icon
207
NOV
NOV
$6.93B
$16M 0.05%
1,767,963
-152,959
-8% -$1.79M
CTRA
208
DELISTED
Coterra Energy
CTRA
$15.6M 0.05%
896,862
-103,753
-10% -$1.94M
PEP icon
209
PepsiCo
PEP
$190B
$15.5M 0.05%
111,757
-3,655
-3% -$497K
DCUE
210
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
$15.5M 0.05%
152,058
-3,247
-2% -$330K
GH icon
211
Guardant Health
GH
$21.7B
$15.4M 0.05%
137,873
+1,399
+1% +$128K
NEE.PRO
212
DELISTED
NextEra Energy, Inc. 4.872% Corporate Units
NEE.PRO
$15.3M 0.05%
283,338
-6,049
-2% -$330K
SOLN
213
DELISTED
The Southern Company
SOLN
$15.2M 0.05%
325,839
-6,956
-2% -$319K
TJX icon
214
TJX Companies
TJX
$174B
$14.8M 0.05%
265,144
+28,998
+12% +$1.56M
CRL icon
215
Charles River Laboratories
CRL
$11.2B
$14.6M 0.05%
64,584
-13,522
-17% -$2.81M
QGEN icon
216
Qiagen
QGEN
$8.54B
$14.5M 0.05%
261,452
-35,700
-12% -$1.85M
OBDC icon
217
Blue Owl Capital
OBDC
$5.34B
$14.5M 0.05%
1,199,716
-165,658
-12% -$2.03M
MCK icon
218
McKesson
MCK
$100B
$14.3M 0.05%
95,818
+8,560
+10% +$1.3M
CLB icon
219
Core Laboratories
CLB
$488M
$13.8M 0.04%
904,856
-4,470
-0.5% -$93.7K
ETN icon
220
Eaton
ETN
$161B
$13.6M 0.04%
133,310
+15,161
+13% +$1.48M
TGT icon
221
Target
TGT
$65.6B
$13.6M 0.04%
86,096
+15,398
+22% +$2.11M
PCGU
222
DELISTED
PG&E Corporation
PCGU
$13.5M 0.04%
+137,376
New +$13.4M
CSCO icon
223
Cisco
CSCO
$457B
$13.4M 0.04%
340,872
-15,339
-4% -$669K
LLY icon
224
Eli Lilly
LLY
$1.02T
$13.2M 0.04%
89,334
-13,891
-13% -$2.15M
SRPT icon
225
Sarepta Therapeutics
SRPT
$1.57B
$13.2M 0.04%
93,896
-12,268
-12% -$1.86M

Similar funds

VanEck Associates's Q3 2020 Portfolio in Review

As of Q3 2020, VanEck Associates held 1,057 positions worth $31.4B, up 9.5% from $28.7B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

VanEck Associates's Q3 2020 filing shows 52 new, 555 increased, 391 reduced and 42 closed positions. Its largest new stake was Corvus Gold Inc. Common Shares: 8,706,556 shares worth $25.6M. The largest sale was Sibanye-Stillwater, an estimated $275M.

By sector, the portfolio is most concentrated in Materials at 59% of assets, up from 59% a quarter earlier, followed by Technology and Healthcare.

  • VanEck Associates's largest Q3 2020 buy was Corvus Gold Inc. Common Shares: 8,706,556 shares worth $25.6M.
  • VanEck Associates added most to SSR Mining in Q3 2020, an estimated $217M increase.
  • VanEck Associates's biggest Q3 2020 reduction was Sibanye-Stillwater, cutting an estimated $275M.
  • VanEck Associates fully exited State Street in Q3 2020, selling an estimated $49.6M.
  • VanEck Associates's ten largest holdings make up 40% of its $31.4B portfolio in Q3 2020.
  • VanEck Associates opened 52 new positions and closed 42 in Q3 2020.
  • VanEck Associates's portfolio value rose 9.5% quarter-over-quarter to $31.4B.

Based on VanEck Associates's 13F filing for Q3 2020, filed 12 Nov 2020.